Genetic susceptibility to bladder cancer
- 1 August 2005
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 366 (9486) , 610-612
- https://doi.org/10.1016/s0140-6736(05)67115-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesThe Lancet, 2005
- Glutathione S-transferases M1, T1, and P1 and Breast Cancer: A Pooled AnalysisCancer Epidemiology, Biomarkers & Prevention, 2004
- Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States)Cancer Causes & Control, 2003
- Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC studyBiomarkers, 2003
- Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer riskCarcinogenesis: Integrative Cancer Research, 2002
- Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE ReviewAmerican Journal of Epidemiology, 2002
- Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative reviewBiomarkers, 2002
- Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studiesInternational Journal of Cancer, 2000